EE05862B1 - Meditsiiniline plaaster - Google Patents
Meditsiiniline plaasterInfo
- Publication number
- EE05862B1 EE05862B1 EEP202200014A EEP202200014A EE05862B1 EE 05862 B1 EE05862 B1 EE 05862B1 EE P202200014 A EEP202200014 A EE P202200014A EE P202200014 A EEP202200014 A EE P202200014A EE 05862 B1 EE05862 B1 EE 05862B1
- Authority
- EE
- Estonia
- Prior art keywords
- medical plaster
- release
- specifically
- sodium salt
- medical
- Prior art date
Links
- 239000011505 plaster Substances 0.000 title abstract 5
- JGMJQSFLQWGYMQ-UHFFFAOYSA-M sodium;2,6-dichloro-n-phenylaniline;acetate Chemical class [Na+].CC([O-])=O.ClC1=CC=CC(Cl)=C1NC1=CC=CC=C1 JGMJQSFLQWGYMQ-UHFFFAOYSA-M 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000000853 adhesive Substances 0.000 abstract 1
- 230000001070 adhesive effect Effects 0.000 abstract 1
- 229960001259 diclofenac Drugs 0.000 abstract 1
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Inorganic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Plant Substances (AREA)
- Finger-Pressure Massage (AREA)
Abstract
Leiutis käsitleb meditsiinilist plaastrit, täpsemalt diklofenakki aeglaselt vabastavat meditsiinilist plaastrit, täpsemalt diklofenaki naatriumsoolal põhinevat meditsiinilist plaastrit, mille koostis võimaldab toimeainet vabastada pidevalt ja lokaalselt, terapeutiliselt aktiivses kontsentratsioonis 24 tunni jooksul, ning samuti polümeerset adhesiivmaatriksit (PSA) kasutamiseks diklofenaki naatriumsoolal põhinevas meditsiinilises plaastris.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT102020000011686A IT202000011686A1 (it) | 2020-05-20 | 2020-05-20 | Cerotto medicato a lento rilascio |
Publications (2)
Publication Number | Publication Date |
---|---|
EE202200014A EE202200014A (et) | 2022-12-15 |
EE05862B1 true EE05862B1 (et) | 2024-01-15 |
Family
ID=71994907
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EEP202200014A EE05862B1 (et) | 2020-05-20 | 2021-05-18 | Meditsiiniline plaaster |
Country Status (35)
Country | Link |
---|---|
US (1) | US20230190668A1 (et) |
EP (1) | EP4153151B1 (et) |
KR (1) | KR20230013033A (et) |
CN (1) | CN115666537A (et) |
AR (1) | AR122136A1 (et) |
AT (1) | AT525409A3 (et) |
BE (1) | BE1028251B1 (et) |
CA (1) | CA3178964A1 (et) |
CH (1) | CH718822B1 (et) |
CZ (1) | CZ2022461A3 (et) |
DE (1) | DE112021002871T5 (et) |
DK (2) | DK4153151T3 (et) |
EE (1) | EE05862B1 (et) |
ES (2) | ES2936185R1 (et) |
FI (1) | FI4153151T3 (et) |
FR (1) | FR3110397A1 (et) |
GB (1) | GB2610106B (et) |
GR (1) | GR1010304B (et) |
HR (1) | HRP20240192T1 (et) |
HU (2) | HUP2200459A2 (et) |
IE (1) | IE20210109A1 (et) |
IT (1) | IT202000011686A1 (et) |
LT (1) | LT4153151T (et) |
LU (1) | LU501245B1 (et) |
MA (1) | MA59594B1 (et) |
MD (1) | MD4153151T2 (et) |
NL (1) | NL2028233B1 (et) |
PL (2) | PL245596B1 (et) |
PT (1) | PT4153151T (et) |
RO (1) | RO137440A2 (et) |
RS (1) | RS65194B1 (et) |
SI (1) | SI4153151T1 (et) |
SK (1) | SK500562022A3 (et) |
TR (1) | TR2021008324A2 (et) |
WO (1) | WO2021234562A1 (et) |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09208463A (ja) * | 1996-02-07 | 1997-08-12 | Tsumura & Co | 経皮吸収性に優れた消炎鎮痛組成物 |
JP4181232B2 (ja) * | 1997-07-18 | 2008-11-12 | 帝國製薬株式会社 | ジクロフェナクナトリウム含有油性外用貼付製剤 |
JP4865958B2 (ja) * | 2001-05-23 | 2012-02-01 | 株式会社トクホン | 鎮痛抗炎症局所作用型の貼付剤 |
CN1215838C (zh) * | 2003-06-25 | 2005-08-24 | 蚌埠丰原医药科技发展有限公司 | 双氯芬酸钠贴剂及其制备方法 |
US20060078604A1 (en) * | 2004-10-08 | 2006-04-13 | Noven Pharmaceuticals, Inc. | Transdermal drug delivery device including an occlusive backing |
EP1877509B1 (en) | 2005-03-17 | 2011-10-12 | Pharmafilm S.R.L. | An aqueous polymeric system for pressure sensitive adhesive matrix preparation |
US20070259029A1 (en) * | 2006-05-08 | 2007-11-08 | Mcentire Edward Enns | Water-dispersible patch containing an active agent for dermal delivery |
BR112013016998A2 (pt) | 2010-12-29 | 2016-10-25 | Pharmafilm S R L | emplastro medicamentoso para a permeação transdérmica melhorada de diclofenaco dietilamônio |
US20140100285A1 (en) * | 2011-05-26 | 2014-04-10 | Novartis Ag | Compositions of percutaneous administration of physiologically active agents |
PT2865378T (pt) * | 2012-06-20 | 2018-01-15 | Hisamitsu Pharmaceutical Co | Adesivo para a pele |
EP3206673B1 (en) | 2014-10-17 | 2024-08-21 | Fidia Farmaceutici S.p.A. | Dermal therapeutic system with high adhesivity |
-
2020
- 2020-05-20 IT IT102020000011686A patent/IT202000011686A1/it unknown
-
2021
- 2021-05-11 GR GR20210100319A patent/GR1010304B/el active IP Right Grant
- 2021-05-18 RO ROA202200733A patent/RO137440A2/ro unknown
- 2021-05-18 DE DE112021002871.5T patent/DE112021002871T5/de active Pending
- 2021-05-18 PL PL442805A patent/PL245596B1/pl unknown
- 2021-05-18 FI FIEP21726205.4T patent/FI4153151T3/fi active
- 2021-05-18 NL NL2028233A patent/NL2028233B1/en active
- 2021-05-18 PL PL21726205.4T patent/PL4153151T3/pl unknown
- 2021-05-18 ES ES202290075A patent/ES2936185R1/es active Pending
- 2021-05-18 LT LTEPPCT/IB2021/054261T patent/LT4153151T/lt unknown
- 2021-05-18 HU HU2200459A patent/HUP2200459A2/hu unknown
- 2021-05-18 KR KR1020227040002A patent/KR20230013033A/ko unknown
- 2021-05-18 HU HUE21726205A patent/HUE066041T2/hu unknown
- 2021-05-18 MA MA59594A patent/MA59594B1/fr unknown
- 2021-05-18 DK DK21726205.4T patent/DK4153151T3/da active
- 2021-05-18 RS RS20240130A patent/RS65194B1/sr unknown
- 2021-05-18 CH CH001380/2022A patent/CH718822B1/it not_active IP Right Cessation
- 2021-05-18 LU LU501245A patent/LU501245B1/fr active IP Right Grant
- 2021-05-18 SI SI202130104T patent/SI4153151T1/sl unknown
- 2021-05-18 AT ATA9160/2021A patent/AT525409A3/de unknown
- 2021-05-18 US US17/925,515 patent/US20230190668A1/en active Pending
- 2021-05-18 SK SK50056-2022A patent/SK500562022A3/sk unknown
- 2021-05-18 ES ES21726205T patent/ES2972189T3/es active Active
- 2021-05-18 EP EP21726205.4A patent/EP4153151B1/en active Active
- 2021-05-18 CZ CZ2022-461A patent/CZ2022461A3/cs unknown
- 2021-05-18 PT PT217262054T patent/PT4153151T/pt unknown
- 2021-05-18 CA CA3178964A patent/CA3178964A1/en active Pending
- 2021-05-18 CN CN202180036277.8A patent/CN115666537A/zh active Pending
- 2021-05-18 EE EEP202200014A patent/EE05862B1/et unknown
- 2021-05-18 WO PCT/IB2021/054261 patent/WO2021234562A1/en active Application Filing
- 2021-05-18 GB GB2217015.3A patent/GB2610106B/en active Active
- 2021-05-18 MD MDE20230333T patent/MD4153151T2/ro unknown
- 2021-05-18 HR HRP20240192TT patent/HRP20240192T1/hr unknown
- 2021-05-19 IE IE20210109A patent/IE20210109A1/en unknown
- 2021-05-19 TR TR2021/008324A patent/TR2021008324A2/tr unknown
- 2021-05-19 FR FR2105212A patent/FR3110397A1/fr active Pending
- 2021-05-20 BE BE20215409A patent/BE1028251B1/fr active IP Right Grant
- 2021-05-20 AR ARP210101380A patent/AR122136A1/es unknown
-
2022
- 2022-11-14 DK DKPA202201037A patent/DK202201037A1/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2007004862A (es) | Nuevos derivados de sulfonamida como moduladores del receptor de glucocorticoides para el tratamiento de enfermedades inflamatorias. | |
MX2008000099A (es) | Composiciones farmaceuticas de liberacion modificada novedosas, y procedimiento de preparacion de dichas composiciones. | |
NZ610701A (en) | Once daily formulation of lacosamide | |
MX2007004861A (es) | Derivados de sulfonamida novedosos como moduladores de receptor glucocorticoide para el tratamiento de enfermedades inflamatorias. | |
ATE383849T1 (de) | Transdermale pharmazeutische zusammensetzung | |
MX2009009623A (es) | Inidol y bencimidazol amidas como inhibidores de la dehidrogenasa hidroxi-esteroide. | |
JP6142379B2 (ja) | 含水貼付剤 | |
DE602006004451D1 (de) | Mucoadhäsive xyloglucan-haltige formulierung für medizinprodukte und pharmazeutische darreichungsformen | |
MX360289B (es) | Composiciones de tapentadol. | |
NZ594618A (en) | Transdermal pharmaceutical preparations | |
EA201500553A1 (ru) | Многодневный пластырь для чрескожного введения ротиготина | |
US8852628B1 (en) | Transdermal drug delivery system for diclofenac | |
ATE476972T1 (de) | Verwendung von valproinsäure zur topischen behandlung von leichter bis mittelschwerer akne vulgaris | |
AR044200A1 (es) | Composicion de fondaparinux sodico de alta pureza ,un procedimiento de preparacion de esta composicion y composiciones farmaceuticas que la contienen como principio activo | |
PE20040416A1 (es) | Formulacion de alta dosis de ibandronato | |
AR038618A1 (es) | Forma poliformica cristalina de clorhidratos de irinotecan | |
WO2008151040A3 (en) | Analgesic coated medical product | |
EE202200014A (et) | Meditsiiniline plaaster | |
UY31058A1 (es) | Formulaciones de aminoacido n-halogenado con compuestos antiinflamatorios | |
RU2013157834A (ru) | Композиции для подкожного введения физиологически активных средств | |
TW200500093A (en) | A platform for transdermal formulations (PTF) | |
NO20064196L (no) | Utvortes preparat for behandling av smertefulle hudskader | |
MXPA05008711A (es) | Uso de r-10-hidroxi-10,11-dihidro-carbamazepina en dolor neuropatico. | |
NZ703464A (en) | Controlled release formulations comprising uncoated discrete unit(s) and an extended release matrix | |
JP5948322B2 (ja) | ピロキシカム含有マトリックスパッチ、ならびにそれを用いる急性および慢性の疼痛および炎症の局所処置の方法 |